Table 5.
IC50 value of inhibition towards IL-4 and TNF-α release
| IC50 value of inhibition | ||
|---|---|---|
| IL-4 | TNF-α | |
| M. oleifera leaf extract | 2.32 ± 0.08 μg/mL | 1.20 ± 0.29 μg/mL |
| M. oleifera seed extract | 4.28 ± 0.05 μg/mL | 2.52 ± 0.33 μg/mL |
| M. oleifera pod extract | 2.74 ± 0.17 μg/mL | 2.52 ± 0.15 μg/mL |
| Ethyl-(E)–undec-6-enoate (1) | 16.91 ± 0.56 μM | 9.90 ± 2.31 μM |
| 3,5,6-trihydroxy-2-(2,3,4,5,6-pentahydroxyphenyl)-4H-chromen-4-one (2) | 12.17 ± 0.13 μM | 6.45 ± 0.26 μM |
| Quercetin (3) | 10.42 ± 0.07 μM | 6.24 ± 0.31 μM |
| Kaempferol (4) | 14.55 ± 3.24 μM | 8.73 ± 0.59 μM |
| β-sitosterol-3-O-glucoside (5) | 7.33 ± 1.76 μM | 5.26 ± 0.00 μM |
| Oleic acid (6) | 8.10 ± 0.26 μM | 10.11 ± 1.49 μM |
| Glucomoringin (7) | 7.59 ± 0.39 μM | 3.86 ± 8.26 μM |
| Stigmasterol (9) | 10.99 ± 1.57 μM | 6.05 ± 16.54 μM |
| Ketotifen fumarate (positive control) |
3.08 ± 0.49 μg/mL (7.24 ± 1.16 μM) |
2.91 ± 0.33 μg/mL (6.85 ± 0.77 μM) |